Based on the HNSCC samples, the high expression of ZEB1 and ZEB2 was associated with advanced and metastatic cancer, and high levels of ZEB1 and ZEB2 predicted poor outcome. This evidence concerns the gene ZEB2 and metastatic malignant neoplasm.